PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2000433
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2000433
According to Stratistics MRC, the Global Pet Genetic Testing & Ancestry Services Market is accounted for $0.48 billion in 2026 and is expected to reach $1.52 billion by 2034 growing at a CAGR of 15.6% during the forecast period. Pet Genetic Testing & Ancestry Services involve DNA-based analysis to identify a pet's breed composition, genetic traits, health risks, and ancestry. These services use saliva or blood samples to provide insights into inherited conditions, behavioral tendencies, and nutritional needs. Results help pet owners and veterinarians make informed decisions regarding preventive healthcare, training, and diet planning. Advanced genomic technologies and databases enhance accuracy and personalization. Growing awareness of pet health and the humanization of pets are driving demand for these services, supporting proactive and data-driven pet care management.
Rising interest in pet breed identification
Pet owners are increasingly curious about the lineage, heritage, and unique traits of their pets, particularly for mixed-breed animals. Genetic insights help in understanding behavioral patterns, dietary requirements, and potential health risks associated with specific breeds. The growing humanization of pets is encouraging owners to invest in advanced diagnostic and analytical services. Additionally, the popularity of personalized pet care solutions is boosting demand for breed identification kits. Social media trends and community sharing of pet ancestry results are further amplifying consumer interest and market expansion.
Limited awareness among pet owners
Many pet owners, especially in developing regions, are unfamiliar with the benefits of genetic testing. The perception that such services are non-essential or luxury offerings restricts widespread adoption. Lack of education regarding genetic disease prevention and breed-specific healthcare also hampers market penetration. Furthermore, limited availability of veterinary guidance on genetic testing reduces consumer confidence. These factors collectively slow down market growth, particularly in price-sensitive and emerging economies.
Integration with veterinary healthcare platforms
Genetic testing data can be combined with veterinary records to provide personalized healthcare plans for pets. This integration enables early detection of hereditary diseases, improving preventive care and treatment outcomes. Veterinary clinics and digital pet health platforms can leverage genetic insights to offer tailored nutrition and wellness programs. The rise of telemedicine and digital health ecosystems further supports seamless data sharing and analysis. Such advancements are expected to enhance the value proposition of genetic testing services and expand their adoption globally.
Accuracy issues affecting consumer trust
Variations in testing methodologies and limited breed databases can lead to inconsistent or unreliable results. Incorrect breed identification or health risk predictions may lead to dissatisfaction among pet owners. Such inaccuracies can damage brand credibility and reduce repeat purchases. Additionally, lack of standardized regulations and quality benchmarks increases the risk of misleading claims. Addressing these challenges is crucial for maintaining consumer trust and ensuring long-term market sustainability.
The COVID-19 pandemic had a mixed impact on the pet genetic testing and ancestry services market. Initially, supply chain disruptions and restrictions on veterinary visits affected product distribution and service accessibility. However, the surge in pet adoption during lockdowns significantly increased the potential customer base. Pet owners spending more time at home showed greater interest in understanding their pets' health and ancestry. The rise of e-commerce platforms facilitated the sale of home-based DNA testing kits. Additionally, growing awareness of preventive healthcare during the pandemic boosted demand for genetic testing services. Overall, the pandemic accelerated digital adoption and long-term growth opportunities in the market.
The DNA testing kits segment is expected to be the largest during the forecast period
The DNA testing kits segment is expected to account for the largest market share during the forecast period as it offers convenience and ease of use for pet owners. These kits enable sample collection at home, eliminating the need for frequent veterinary visits. Increasing availability of affordable and user-friendly testing kits is driving widespread adoption. Companies are continuously innovating to provide faster and more accurate results. The growing popularity of direct-to-consumer models is further supporting segment growth. Additionally, strong online distribution channels are enhancing product accessibility across global markets.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing professional involvement in genetic testing services. Veterinary clinics provide expert guidance, improving the accuracy and reliability of test results. Growing awareness of preventive healthcare among pet owners is driving demand for clinic-based testing. Integration of genetic data into routine veterinary care is further enhancing service adoption. Clinics are also offering comprehensive health packages that include genetic screening. This trend is expected to accelerate the growth of this segment significantly.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong consumer awareness. The presence of leading market players and advanced veterinary infrastructure supports regional growth. Pet owners in the region are more willing to spend on premium and preventive healthcare services. The increasing trend of pet humanization is also driving demand for genetic testing solutions. Additionally, well-established e-commerce and direct-to-consumer distribution channels enhance product accessibility. Favorable regulatory frameworks further contribute to the dominance of this region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid urbanization and rising disposable incomes. Increasing pet adoption rates, particularly in emerging economies, are expanding the customer base. Growing awareness about pet health and wellness is encouraging the use of genetic testing services. The expansion of veterinary infrastructure and digital healthcare platforms supports market growth. Additionally, the entry of global players and local startups is intensifying market competition. These factors collectively position Asia Pacific as the fastest-growing region in the market.
Key players in the market
Some of the key players in Pet Genetic Testing & Ancestry Services Market include Basepaws, Inc., Embark Veterinary, Inc., Zoetis Inc., Neogen Corporation, Animal Genetics, Inc., Orivet Genetic Pet Care, DNA My Dog, Paw Print Genetics, PetGenoma, EasyDNA, IdentiGEN Ltd., Genoscoper Laboratories, Illumina, Inc., Thermo Fisher Scientific Inc. and Mapmygenome India Ltd.
In September 2024, Embark introduced a veterinarian- and geneticist-backed supplement range, marking its entry into broader pet health beyond DNA testing. This expansion positioned the company as a more holistic pet wellness provider.
In June 2022, Zoetis officially completed the acquisition of Basepaws. The deal strengthened Zoetis's portfolio by integrating Basepaws' genetic insights, enabling veterinarians and pet owners to better understand disease risks and improve early detection.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.